Monica Gandhi, MD
Enriched profileProfessor of Medicine; Associate Division Chief (Clinical Operations/Education), Division of HIV, Infectious Diseases, and Global Medicine · University of California, San Francisco (UCSF)
Monica Gandhi is Professor of Medicine; Associate Division Chief (Clinical Operations/Education), Division of HIV, Infectious Diseases, and Global Medicine at University of California, San Francisco (UCSF). OpenAlex indexes 462 publications with 15,992 citations (h-index 66); ClinicalTrials.gov lists 5 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Monica Gandhi, MD, is Professor of Medicine at University of California, San Francisco (UCSF) / Zuckerberg San Francisco General Hospital. The public record shows 462 publications with 15,992 citations (h-index 66), centered on HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 7 companies, 21 NIH-funded awards (2004–2026).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: HIV/AIDS Research and Interventions
- 5 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 252.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →commonwealthclub.org ↗
- Advocated for a "risk-reduction" (vs. zero-COVID) public-health approach during the COVID-19 pandemic
supporting vaccination and masking while questioning broad lockdown measures' effects on vulnerable populations
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:
- Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA)
Sponsor: University of California, San Francisco
- Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)
Sponsor: University of California, San Francisco
- Contingency Management for PrEP Adherence and/or Methamphetamine Use
Sponsor: University of California, Los Angeles
Industry payments
Updated 27 Aug 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20255 payments$19,407openpaymentsdata.cms.gov ↗
- SANOFI PASTEUR INC.Program year20254 payments$10,086openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year20255 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
36.2%Gabapentinoids5.2%Gabapentin66%Pregabalin35%Part D<11 patientsSSRI5%Fluoxetine Hcl35%Trazodone Hcl26%Paroxetine Hcl25%Citalopram Hbr14%Part D<11 patientsAnti-infectives
27.2%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor8.8%Tivicay60%Dovato17%Cabenuva14%Juluca9%Part D<11 patientsProtease Inhibitor6.5%Prezcobix49%Ritonavir24%Symtuza14%Darunavir13%Part D<11 patientsCardiovascular
12.4%Statin5.4%Atorvastatin Calcium78%Rosuvastatin Calcium22%Part D<11 patientsCalcium channel blocker2.1%Amlodipine Besylate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
21 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- UCSF-Bay Area Center for AIDS Research
University of California, San Francisco
FY2026$3,097,293P30AI027763 - Developing a U.S. National Cohort to Improve Virologic Suppression among Stimulant-using Men Living with HIV.
University of California, San Francisco
FY2026$1,787,418UH3DA058304 - “Hair Lengthening”: Using Hair Levels to Interpret Long-Acting PrEP Studies.
University of California, San Francisco
FY2026$779,280R37AI098472
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Virologic Outcomes After LA ART Initiation with and without Viremia in Two Large U.S. Clinic Cohorts.
Clinical infectious diseases
Article2026 - Hair Testing to Detect Long-term Methamphetamine Use in People Living with and without HIV.
Journal of acquired immune deficiency syndromes (1999)
Article2026 - Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-Term Pre-exposure Prophylaxis Adherence for US Men Who Have Sex With Men in Pilot RCT.
Clinical infectious diseases
Clinical Trial2026 - Trends in HIV Viral Suppression in the POP-UP Low-Barrier Care Program for People With HIV Experiencing Homelessness or Unstable Housing.
Open forum infectious diseases
Article2026 - Integrating HIV and Stimulant-Use Disorder Treatment: A Pilot Implementation Effectiveness Trial of Contingency Management in HIV Care.
Clinical infectious diseases
Article2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Sex Differences in Pharmacokinetics and Pharmacodynamics537 citations2004
- 03
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/monica-gandhi-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/monica-gandhi-a43b4aab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
theconversation.com/profiles/monica-gandhi-1080710
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →theconversation.com ↗
Mentions by others
where others cite or feature them- Other
cfar.ucsf.edu/news/monica-gandhi-md-mph-appointed-new-ucsf-gladstone-cfar-director
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.ucsf.edu ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- Board certification
Infectious Disease (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsf.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.ucsf.edu ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsf.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsf.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsf.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
UCSF-Bay Area Center for AIDS Research (CFAR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.ucsf.edu ↗ - Medical Director / Education Director
HIV Clinic at San Francisco General Hospital ("Ward 86")
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsf.edu ↗ - Director
UCSF Hair Analytical Laboratory (HAL)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cfar.ucsf.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →commonwealthclub.org ↗
- Contributor to The Atlantic
The Washington Post, and The Conversation on HIV/COVID public health topics
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Gregory Marcus, MD
University of California, San Francisco (UCSF)
Eric Small, MD
University of California, San Francisco (UCSF)
Adam Boxer, MD
University of California, San Francisco (UCSF)